Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: Bioconjug Chem. 2021 Aug 20;32(9):1935–1946. doi: 10.1021/acs.bioconjchem.1c00326

Figure 2:

Figure 2:

Antibody-based pre-targeting for delivery to sites of disease bearing a specific biomarker, coupled with a secondary delivery approach and in situ targeting driven by (A) monovalent host–guest motifs or (B) complementary oligonucleotide sequences designed for hybridization.